-
LEXX Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Lexaria Bioscience (LEXX)
Company Profile
Quarter (USD) | Nov 24 | Aug 24 | May 24 | Feb 24 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Aug 24 | Aug 23 | Aug 22 | Aug 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 8.08 mm | 8.08 mm | 8.08 mm | 8.08 mm | 8.08 mm | 8.08 mm |
Cash burn (monthly) | (no burn) | (no burn) | 896.90 k | 608.72 k | 908.68 k | 541.95 k |
Cash used (since last report) | n/a | n/a | 2.33 mm | 1.58 mm | 2.36 mm | 1.41 mm |
Cash remaining | n/a | n/a | 5.74 mm | 6.49 mm | 5.71 mm | 6.67 mm |
Runway (months of cash) | n/a | n/a | 6.4 | 10.7 | 6.3 | 12.3 |
13F holders | Current |
---|---|
Total holders | 28 |
Opened positions | 27 |
Closed positions | 3 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 3.22 bn |
Total shares | 1.35 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Invenomic Capital Management | 475.77 k | $1.45 bn |
L1 Capital Global Opportunities Master Fund | 285.71 k | $1.28 mm |
Geode Capital Management | 150.39 k | $458.79 mm |
Vanguard | 109.02 k | $332.52 mm |
GenTrust | 60.00 k | $183.00 mm |
Raymond James Financial Services Advisors | 44.90 k | $136.95 mm |
STT State Street | 39.30 k | $119.87 mm |
BlackRock | 27.45 k | $83.71 mm |
Welch | 24.00 k | $73.20 mm |
MS Morgan Stanley | 22.98 k | $70.10 mm |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
7 Jan 25 | Bunka Christopher | Restricted Stock Award | Grant | Acquire A | No | No | 0 | 100,000 | 0.00 | 373,543 |
3 Dec 24 | Christopher Richard | common shares | Buy | Acquire P | No | No | 2.4722 | 27,172 | 67.17 k | 50,000 |
2 Dec 24 | Christopher Richard | common shares | Buy | Acquire P | No | No | 2.2436 | 22,828 | 51.22 k | 22,828 |